{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:11:11Z","timestamp":1778191871539,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Changzhou Medical Center Project","award":["CMCB202421"],"award-info":[{"award-number":["CMCB202421"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04308-4","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:18:21Z","timestamp":1774934301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FOXA2 promotes the occurrence and development of osteosarcoma cells by regulating ferroptosis through the Rheb\/mTOR axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiahao","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"4308_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040976","author":"I Corre","year":"2020","unstructured":"Corre I, Verrecchia F, Crenn V, Redini F, Trichet V. The osteosarcoma microenvironment: a complex but targetable ecosystem. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9040976.","journal-title":"Cells"},{"key":"4308_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021;500:1\u201310.","journal-title":"Cancer Lett"},{"key":"4308_CR3","doi-asserted-by":"publisher","first-page":"e11131","DOI":"10.15252\/emmm.201911131","volume":"12","author":"TG Gr\u00fcnewald","year":"2020","unstructured":"Gr\u00fcnewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F, et al. Sarcoma treatment in the era of molecular medicine. EMBO Mol Med. 2020;12:e11131.","journal-title":"EMBO Mol Med"},{"key":"4308_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11914-023-00803-9","volume":"21","author":"I Panez-Toro","year":"2023","unstructured":"Panez-Toro I, Mu\u00f1oz-Garc\u00eda J, Vargas-Franco JW, Renodon-Corni\u00e8re A, Heymann MF, L\u00e9zot F, et al. Advances in osteosarcoma. Curr Osteoporos Rep. 2023;21:330\u201343.","journal-title":"Curr Osteoporos Rep"},{"key":"4308_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1080\/21645515.2020.1824499","volume":"17","author":"K Yahiro","year":"2021","unstructured":"Yahiro K, Matsumoto Y. Immunotherapy for osteosarcoma. Hum Vaccin Immunother. 2021;17:1294\u20135.","journal-title":"Hum Vaccin Immunother"},{"key":"4308_CR6","doi-asserted-by":"publisher","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","volume":"21 Suppl 7","author":"J Ritter","year":"2010","unstructured":"Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21 Suppl 7:vii320\u20135.","journal-title":"Ann Oncol"},{"key":"4308_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41420-024-01936-1","volume":"10","author":"N Liu","year":"2024","unstructured":"Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M. FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer. Cell Death Discov. 2024;10:172.","journal-title":"Cell Death Discov"},{"key":"4308_CR8","first-page":"1495","volume":"25","author":"M Katoh","year":"2004","unstructured":"Katoh M, Katoh M. Human FOX gene family (review). Int J Oncol. 2004;25:1495\u2013500.","journal-title":"Int J Oncol"},{"key":"4308_CR9","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ccell.2022.10.011","volume":"40","author":"M Han","year":"2022","unstructured":"Han M, Li F, Zhang Y, Dai P, He J, Li Y, et al. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer. Cancer Cell. 2022;40:1306-23.e8.","journal-title":"Cancer Cell"},{"key":"4308_CR10","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.devcel.2022.06.017","volume":"57","author":"G Orstad","year":"2022","unstructured":"Orstad G, Fort G, Parnell TJ, Jones A, Stubben C, Lohman B, et al. FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma. Dev Cell. 2022;57:1866-82.e10.","journal-title":"Dev Cell"},{"key":"4308_CR11","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/15548627.2025.2489335","volume":"21","author":"J Yuan","year":"2025","unstructured":"Yuan J, Ma J, Zhang F, Wang T, Jian X, Wang B, et al. Neutrophil-derived serine proteases induce FOXA2-mediated autophagy dysfunction and exacerbate colitis-associated carcinogenesis via protease activated receptor 2. Autophagy. 2025;21:2130\u201347.","journal-title":"Autophagy"},{"key":"4308_CR12","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.7150\/jca.37393","volume":"11","author":"S Jiang","year":"2020","unstructured":"Jiang S, Zhou F, Zhang Y, Zhou W, Zhu L, Zhang M, et al. Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation. J Cancer. 2020;11:3623\u201333.","journal-title":"J Cancer"},{"key":"4308_CR13","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1038\/s41467-025-60141-5","volume":"16","author":"K Kawasaki","year":"2025","unstructured":"Kawasaki K, Salehi S, Zhan YA, Chen K, Lee JH, Salataj E, et al. FOXA2 promotes metastatic competence in small cell lung cancer. Nat Commun. 2025;16:4865.","journal-title":"Nat Commun"},{"key":"4308_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10616-021-00475-2","volume":"73","author":"G Ma","year":"2021","unstructured":"Ma G, Chen J, Wei T, Wang J, Chen W. Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2\/LATS2\/YAP axis. Cytotechnology. 2021;73:523\u201337.","journal-title":"Cytotechnology"},{"key":"4308_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102488","author":"A Vadhan","year":"2022","unstructured":"Vadhan A, Hou MF, Vijayaraghavan P, Wu YC, Hu SC, Wang YM, et al. CD44 promotes breast cancer metastasis through AKT-mediated downregulation of nuclear FOXA2. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10102488.","journal-title":"Biomedicines"},{"key":"4308_CR16","doi-asserted-by":"publisher","first-page":"746030","DOI":"10.3389\/fonc.2022.746030","volume":"12","author":"C Qiu","year":"2022","unstructured":"Qiu C, Liu T, Luo D, Luan D, Cheng L, Wang S. Novel therapeutic savior for osteosarcoma: the endorsement of ferroptosis. Front Oncol. 2022;12:746030.","journal-title":"Front Oncol"},{"key":"4308_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4308_CR18","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215\u201327.","journal-title":"Mol Cell"},{"key":"4308_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41419-024-07135-1","volume":"15","author":"SY Chen","year":"2024","unstructured":"Chen SY, Wu J, Chen Y, Wang YE, Setayeshpour Y, Federico C, et al. NINJ1 regulates ferroptosis via xCT antiporter interaction and CoA modulation. Cell Death Dis. 2024;15:755.","journal-title":"Cell Death Dis"},{"key":"4308_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC, et al. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol. 2023;79:362\u201377.","journal-title":"J Hepatol"},{"key":"4308_CR21","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer. 2023;1878:188890.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4308_CR22","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/DDDT.S332847","volume":"15","author":"GN He","year":"2021","unstructured":"He GN, Bao NR, Wang S, Xi M, Zhang TH, Chen FS. Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1\/miR-214-3p\/GPX4. Drug Des Devel Ther. 2021;15:3965\u201378.","journal-title":"Drug Des Devel Ther"},{"key":"4308_CR23","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.59404","volume":"17","author":"R Wei","year":"2021","unstructured":"Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021;17:2703\u201317.","journal-title":"Int J Biol Sci"},{"key":"4308_CR24","doi-asserted-by":"publisher","first-page":"216147","DOI":"10.1016\/j.canlet.2023.216147","volume":"561","author":"R Zhang","year":"2023","unstructured":"Zhang R, Kang R, Tang D. Ferroptosis in gastrointestinal cancer: from mechanisms to implications. Cancer Lett. 2023;561:216147.","journal-title":"Cancer Lett"},{"key":"4308_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"4308_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer. 2023;22:113.","journal-title":"Mol Cancer"},{"key":"4308_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12951-023-02129-1","volume":"21","author":"W Chen","year":"2023","unstructured":"Chen W, Li Z, Yu N, Zhang L, Li H, Chen Y, et al. Bone-targeting exosome nanoparticles activate Keap1 \/ Nrf2 \/ GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells. J Nanobiotechnology. 2023;21:355.","journal-title":"J Nanobiotechnology"},{"key":"4308_CR28","doi-asserted-by":"publisher","first-page":"1031779","DOI":"10.3389\/fonc.2022.1031779","volume":"12","author":"X Liu","year":"2022","unstructured":"Liu X, Du S, Wang S, Ye K. Ferroptosis in osteosarcoma: a promising future. Front Oncol. 2022;12:1031779.","journal-title":"Front Oncol"},{"key":"4308_CR29","doi-asserted-by":"publisher","first-page":"11354","DOI":"10.3168\/jds.2018-14461","volume":"101","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zhou Z, Peng J, Loor JJ. Methionine and valine activate the mammalian target of rapamycin complex 1 pathway through heterodimeric amino acid taste receptor (TAS1R1\/TAS1R3) and intracellular Ca(2+) in bovine mammary epithelial cells. J Dairy Sci. 2018;101:11354\u201363.","journal-title":"J Dairy Sci"},{"key":"4308_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.dld.2023.09.017","volume":"56","author":"X Yan","year":"2024","unstructured":"Yan X, Huang S, Li H, Feng Z, Kong J, Liu J. The causal effect of mTORC1-dependent circulating protein levels on nonalcoholic fatty liver disease: a Mendelian randomization study. Dig Liver Dis. 2024;56:559\u201364.","journal-title":"Dig Liver Dis"},{"key":"4308_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138.","journal-title":"Mol Cancer"},{"key":"4308_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-023-06262-5","volume":"14","author":"E Cosialls","year":"2023","unstructured":"Cosialls E, Pacreau E, Duruel C, Ceccacci S, Elhage R, Desterke C, et al. mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions. Cell Death Dis. 2023;14:744.","journal-title":"Cell Death Dis"},{"key":"4308_CR33","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117:31189\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4308_CR34","doi-asserted-by":"publisher","first-page":"115681","DOI":"10.1016\/j.celrep.2025.115681","volume":"44","author":"J Chen","year":"2025","unstructured":"Chen J, Huang C, Mei J, Lin Q, Chen W, Tang J, et al. OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Rep. 2025;44:115681.","journal-title":"Cell Rep"},{"key":"4308_CR35","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1111\/cas.15779","volume":"114","author":"Y Weng","year":"2023","unstructured":"Weng Y, Duan W, Yu X, Wu F, Yang D, Jiang Y, et al. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis. Cancer Sci. 2023;114:2345\u201359.","journal-title":"Cancer Sci"},{"key":"4308_CR36","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1038\/s41467-024-49234-9","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Townley SL, Zhang S, Liu M, Li M, Labaf M, et al. FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer. Nat Commun. 2024;15:4914.","journal-title":"Nat Commun"},{"key":"4308_CR37","doi-asserted-by":"publisher","first-page":"e2304521","DOI":"10.1002\/advs.202304521","volume":"10","author":"X Liu","year":"2023","unstructured":"Liu X, Yan C, Chang C, Meng F, Shen W, Wang S, et al. FOXA2 suppression by TRIM36 exerts anti-tumor role in colorectal cancer via inducing NRF2\/GPX4-regulated ferroptosis. Adv Sci (Weinh). 2023;10:e2304521.","journal-title":"Adv Sci (Weinh)"},{"key":"4308_CR38","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z. GPX4, ferroptosis, and diseases. Biomed Pharmacother. 2024;174:116512.","journal-title":"Biomed Pharmacother"},{"key":"4308_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"4308_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3892\/or.2016.4922","volume":"36","author":"K Hu","year":"2016","unstructured":"Hu K, Dai HB, Qiu ZL. mTOR signaling in osteosarcoma: oncogenesis and therapeutic aspects (Review). Oncol Rep. 2016;36:1219\u201325.","journal-title":"Oncol Rep"},{"key":"4308_CR41","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18:744\u201357.","journal-title":"Nat Rev Cancer"},{"key":"4308_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12935-019-0810-5","volume":"19","author":"J Cao","year":"2019","unstructured":"Cao J, Wang X, Wang D, Ma R, Li X, Feng H, et al. PGC-1\u03b2 cooperating with FOXA2 inhibits proliferation and migration of breast cancer cells. Cancer Cell Int. 2019;19:93.","journal-title":"Cancer Cell Int"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04308-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04308-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04308-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:49:30Z","timestamp":1778190570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04308-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04308-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research medical ethics committee of the Affiliated Hospital of the Nanjing Medical University Animal Protection and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}